Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis)
Featured Articles
(NPR/Shots blog) Aug 16, 2018 - Aaron Reid is lying in a hospital bed at the National Institutes of Health when doctors arrive to make sure he's ready for his experimental treatment. "How's your night? Any issues?" asks Dr. Katherine Barnett, a pediatric oncologist, as they begin to examine Reid. Reid, 20, of Lucedale, Miss., has...
Read Article
(Daiichi Sankyo) Aug 1, 2018 - Daiichi Sankyo Company, Limited announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to quizartinib, an investigational FLT3 inhibitor, for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia (AML). “There have...
Read Article
Latest Articles
August 17, 2018
August 17, 2018
August 16, 2018
August 16, 2018
August 15, 2018
August 14, 2018
August 13, 2018
August 09, 2018
View More
News Commentary
Editor Image
09 Jul, 2018 | by Winston Wong, PharmD
The math is simple. Under the proposed agreement, we pay for all doses of the...
View Comment
Editor Image
05 Apr, 2018 | by Winston Wong, PharmD
From a payer perspective, the CMS approval for coverage means that...
View Comment
View More
OBR Blog
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) blog entries.